ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference

Show Health and Fitness Publications

Mon, December 8, 2008

[ Mon, Dec 08th 2008 ] - Market Wire

Acusphere, Inc. Announces Posting of Briefing Doc .. nal Drugs Advisory Committee Meeting on Imagify "

[ Mon, Dec 08th 2008 ] - Market Wire

Bio-Imaging Technologies Partners with AG Mednet .. fer Complete Imaging Solution for Clinical Trials

[ Mon, Dec 08th 2008 ] - Market Wire

Neoprobe Achieves Final Milestone in $13 Million .. sitive Phase 3 Breast Cancer and Melanoma Results

[ Mon, Dec 08th 2008 ] - Market Wire

Data from Pivotal Study Show Medtronic Deep Brain .. ced Seizure Rate in Patients with Severe Epilepsy

[ Mon, Dec 08th 2008 ] - Market Wire

Orthofix International Reports Previously-Filed False Claims Act Complaint is Unsealed

[ Mon, Dec 08th 2008 ] - Market Wire

ZIOPHARM Presents Positive Darinaparsin Phase II Data at ASH Meeting

[ Mon, Dec 08th 2008 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. sent at RBC Capital Markets Healthcare Conference

[ Mon, Dec 08th 2008 ] - Market Wire

Importante gruppo cooperativo di ricerca nel linf .. IMID per uno studio di primaria importanza condo

[ Mon, Dec 08th 2008 ] - Market Wire

Premier Cooperative Group in Adult Lymphoma Resea .. ajor Study in Disease s Largest Patient Populati

[ Mon, Dec 08th 2008 ] - Market Wire

Bristol-Myers Squibb and AstraZeneca Announce Exp .. tion to Develop and Commercialize Dapagliflozin i

[ Mon, Dec 08th 2008 ] - Market Wire

Relazione su due presentazioni ASH: Attivit e t .. in pazienti con leucemia linfocitica cronica sin

[ Mon, Dec 08th 2008 ] - Market Wire

Emergent BioSolutions to Webcast Presentation at .. ealthcare Conference on Wednesday, January 14, 20

[ Mon, Dec 08th 2008 ] - Market Wire

Cytori Demonstrates Benefit of Adipose-Derived St .. Cells in Spinal Disc Repair in Preclinical Study

[ Mon, Dec 08th 2008 ] - Market Wire

VIVUS To Participate in Obesity Panel at the 2008 RBC Capital Markets Healthcare Conference

[ Mon, Dec 08th 2008 ] - Market Wire

ImmunoGen, Inc. Announces Genentech s Fifth TAP Technology License

Sun, December 7, 2008

[ Sun, Dec 07th 2008 ] - Market Wire

Crucell N.V.: Crucell Announces Registration of Hepavax-Gene(R) in China

[ Sun, Dec 07th 2008 ] - Market Wire

Exelixis Reports Phase 1 Data for XL019 at ASH Annual Meeting

[ Sun, Dec 07th 2008 ] - Market Wire

ARIAD To Hold Conference Call on Monday Morning, December 8, 2008

[ Sun, Dec 07th 2008 ] - Market Wire

Allos Therapeutics Announces Top Line Results fro .. l of Pralatrexate in Patients with Relapsed or Re

Sat, December 6, 2008

[ Sat, Dec 06th 2008 ] - Market Wire

Seattle Genetics Reports Objective Responses with .. acetuzumab in Phase II Non-Hodgkin Lymphoma Trial

Fri, December 5, 2008

[ Fri, Dec 05th 2008 ] - Market Wire

Health Net and the USO of Metropolitan Washington Team Up for Annual Celebration of Children

[ Fri, Dec 05th 2008 ] - Market Wire

Introgen Common Stock to be Delisted from the Nasdaq Stock Market

[ Fri, Dec 05th 2008 ] - Market Wire

New England Journal of Medicine ver ffentlicht Da .. on Viread bei der Behandlung chronischer Hepatit

[ Fri, Dec 05th 2008 ] - Market Wire

Coventry Health Care Appoints Allen Wise as Executive Chairman

[ Fri, Dec 05th 2008 ] - Market Wire

Curis to Present at RBC Capital Markets 2008 Healthcare Conference

[ Fri, Dec 05th 2008 ] - Market Wire

KV Pharmaceutical Announces Changes in Senior Management

[ Fri, Dec 05th 2008 ] - Market Wire

ONI BioPharma Inc.: ONI BioPharma Announces Proposed Rights Offering to Shareholders

[ Fri, Dec 05th 2008 ] - Market Wire

CytoCore CEO Continues to Purchase Shares of CYOE in the Open Market

[ Fri, Dec 05th 2008 ] - Market Wire

Ore Pharmaceuticals Announces Completion of Multi .. inical Phase 1 Trial; Presents GL1001 Preclinical

[ Fri, Dec 05th 2008 ] - Market Wire

Company Profile for Alphatec Spine

[ Fri, Dec 05th 2008 ] - Market Wire

FDA Advisory Committee to Discuss Genzyme s Synvisc-One PMA on Tuesday

[ Fri, Dec 05th 2008 ] - Market Wire

Candela to Seek Stockholder Approval Prior to Certain Issuances of Preferred Stock

[ Fri, Dec 05th 2008 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Precli .. a Regarding Ispinesib to Be Presented at the 31st

[ Fri, Dec 05th 2008 ] - Market Wire

St. Jude Medical Announces Neuromodulation Divisi .. rand Identity at 12th Annual North American Neuro

[ Fri, Dec 05th 2008 ] - Market Wire

Resumen: Publicados en el New England Journal of .. an la eficacia de Viread en el tratamiento de la

Thu, December 4, 2008

[ Thu, Dec 04th 2008 ] - Market Wire

PDL BioPharma, Inc.: David Parkinson, M.D. Elected to Facet Biotech's Board of Directors

[ Thu, Dec 04th 2008 ] - Market Wire

NitroMed Receives Unsolicited Acquisition Proposal from Deerfield Management

[ Thu, Dec 04th 2008 ] - Market Wire

AmSurg Corp. to Present at the RBC Capital Markets 2008 Healthcare Conference

[ Thu, Dec 04th 2008 ] - Market Wire

Assisted Living Concepts, Inc.: Assisted Living C .. pts, Inc. to Attend New York Investor Conferences

[ Thu, Dec 04th 2008 ] - Market Wire

SCOR: Moody's upgrades SCOR to 'A2'

[ Thu, Dec 04th 2008 ] - Market Wire

Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

[ Thu, Dec 04th 2008 ] - Market Wire

Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial

[ Thu, Dec 04th 2008 ] - Market Wire

Jonathan Lewis, MD, PhD, Appointed to Scientific .. ory Council of the Hope Funds for Cancer Research

[ Thu, Dec 04th 2008 ] - Market Wire

Novelos Therapeutics and Academic Collaborators P .. Posters at 2008 AACR Tumor Immunology Conference

[ Thu, Dec 04th 2008 ] - Market Wire

Tesetaxel, a Leading Oral Taxane in Clinical Deve .. ation as an Orphan Drug for Treatment of Patients

[ Thu, Dec 04th 2008 ] - Market Wire

BioSante Pharmaceuticals Signs Elestrin " Marketing Agreement with Azur Pharma

[ Thu, Dec 04th 2008 ] - Market Wire

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on December 9, 2008

[ Thu, Dec 04th 2008 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of Panel Sessio .. he RBC Capital Markets 2008 Healthcare Conference

[ Thu, Dec 04th 2008 ] - Market Wire

Sirona Announces $50 Million Share Repurchase Authorization

[ Thu, Dec 04th 2008 ] - Market Wire

Centene Corporation Names Aaron W. Brace as President and CEO of South Carolina Subsidiary

Wed, December 3, 2008

[ Wed, Dec 03rd 2008 ] - Market Wire

AngioDynamics Implements Leadership Development P .. eliminary Fiscal Second Quarter Financial Results

[ Wed, Dec 03rd 2008 ] - Market Wire

Alphatec Spine to Present at the RBC Healthcare Conference

[ Wed, Dec 03rd 2008 ] - Market Wire

Biomoda, Inc.: NM Tech, Biomoda Win Legislative Support for Lung Cancer Screening

[ Wed, Dec 03rd 2008 ] - Market Wire

Zila to Report Fiscal 2009 First Quarter Financia .. s and Host Investor Conference Call on December 8

[ Wed, Dec 03rd 2008 ] - Market Wire

CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases

[ Wed, Dec 03rd 2008 ] - Market Wire

PerkinElmer Announces Strategic Acquisition of Arnel Inc.

[ Wed, Dec 03rd 2008 ] - Market Wire

Aspect Medical Systems Repurchases $35 Million of Its 2.5% Convertible Senior Notes Due 2014

[ Wed, Dec 03rd 2008 ] - Market Wire

Health Net Federal Services Is Awarded URAC Healt .. on Management and Case Management Reaccreditation

[ Wed, Dec 03rd 2008 ] - Market Wire

Synta Pharmaceuticals to Participate in the RBC Capital Markets Healthcare Conference

[ Wed, Dec 03rd 2008 ] - Market Wire

Somaxon Pharmaceuticals to Present at the RBC Capital Markets Healthcare Conference

[ Wed, Dec 03rd 2008 ] - Market Wire

Oscient Pharmaceuticals Receives Paragraph IV Certification Notice for ANTARA

[ Wed, Dec 03rd 2008 ] - Market Wire

Protherics PLC: Offer Update

[ Wed, Dec 03rd 2008 ] - Market Wire

Celgene Corporation and Acceleron Pharma to Prese .. nnual Meeting of the American Society of Hematolo

[ Wed, Dec 03rd 2008 ] - Market Wire

Results of Studies of Eslicarbazepine Acetate for .. Be Presented at American Epilepsy Society Annual

[ Wed, Dec 03rd 2008 ] - Market Wire

Zacks Bull and Bear of the Day Highlights: ViroPh .. s, Union Pacific, Methanex and L-3 Communications

Tue, December 2, 2008

[ Tue, Dec 02nd 2008 ] - Market Wire

Trinity Biotech: Trinity Biotech Announces US$6m of Cost Reduction Measures

[ Tue, Dec 02nd 2008 ] - Market Wire

Dr. Edmund Pezalla Named President of the Pharmacy and Therapeutics Society

[ Tue, Dec 02nd 2008 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. Research Institute (NNRI) Collaborate to Test Flu

[ Tue, Dec 02nd 2008 ] - Market Wire

Northland Resources Inc.: Northland Resources Inc .. g) Concession Granted for Tapuli Iron Ore Project

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra

[ Tue, Dec 02nd 2008 ] - Market Wire

LHC Group Expands Footprint to 16 States with Initial Entry into Oklahoma

[ Tue, Dec 02nd 2008 ] - Market Wire

Metabolic Research, Inc. Expands Broadcast Programs

[ Tue, Dec 02nd 2008 ] - Market Wire

Targeted Genetics: Targeted Genetics Realigns Pro .. Priorities and Implements Cost Reduction Measures

[ Tue, Dec 02nd 2008 ] - Market Wire

Protalix BioTherapeutics Announces Completion of .. votal Phase III Clinical Trial of Gaucher Disease

[ Tue, Dec 02nd 2008 ] - Market Wire

Oculus Innovative Sciences Announces Agreement wi .. Development of Microcyn Technology Use in Taiwa

[ Tue, Dec 02nd 2008 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. ls Appoints Gary Titus as Chief Financial Officer

[ Tue, Dec 02nd 2008 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Cuts Quarterly Fixed Costs by $2 Million or 20 Percent

[ Tue, Dec 02nd 2008 ] - Market Wire

VIVUS to Present at J.P. Morgan 2008 SMid Cap Conference

[ Tue, Dec 02nd 2008 ] - Market Wire

Applied Biosystems " Part of Life Technologies .. spond to Melamine Contamination in Dairy Products

[ Tue, Dec 02nd 2008 ] - Market Wire

Titan Pharmaceuticals Announces Reduction in Force

Mon, December 1, 2008

[ Mon, Dec 01st 2008 ] - Market Wire

Next-Generation Noninvasive Diagnostic Technology .. etal Down Syndrome in First Trimester of Pregnanc

[ Mon, Dec 01st 2008 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio Donates HIV Te .. to Support World AIDS Day 2008 Testing Initiative

[ Mon, Dec 01st 2008 ] - Market Wire

Healthline Networks, Inc.: Healthline Networks Se .. h and Advertising Partner for Optumhealth's New C

[ Mon, Dec 01st 2008 ] - Market Wire

Daxor Corp.: Daxor Announces Special Year-End Dividend

[ Mon, Dec 01st 2008 ] - Market Wire

DIANOR RESOURCES INC.: Dianor Resources Signs Def .. ition of Surface Rights to Leadbetter Extension P

[ Mon, Dec 01st 2008 ] - Market Wire

FONAR Corporation: FONAR Granted Continued Listing by NASDAQ Panel

[ Mon, Dec 01st 2008 ] - Market Wire

OptumHealth Launches Consumer-Focused Health Info .. pon Its Expertise in Serving 60 Million Americans

[ Mon, Dec 01st 2008 ] - Market Wire

DexComTM Receives CE Mark Approval for the SEVEN Continuous Glucose Monitoring System

[ Mon, Dec 01st 2008 ] - Market Wire

Del Medical Systems Group Launches TITAN Family of Digital Radiographic Systems

[ Mon, Dec 01st 2008 ] - Market Wire

OR-Live, Inc.: REMINDER: MAKOplasty(R) Robotic Ar .. tial Knee Resurfacing -- A New Level of Precision

[ Mon, Dec 01st 2008 ] - Market Wire

Imaging3, Inc.: Imaging3 CEO Opens RSNA 2008 Conf .. ages and Interview With Leading Trade Publication

[ Mon, Dec 01st 2008 ] - Market Wire

SonoSite Announces the New S-GYN "

[ Mon, Dec 01st 2008 ] - Market Wire

Acorda Therapeutics Elects John P. Kelley to Board of Directors

[ Mon, Dec 01st 2008 ] - Market Wire

Spectrum Pharmaceuticals to Host Conference Call .. ling ZEVALIN Joint Venture and Near-Term Strategy

[ Mon, Dec 01st 2008 ] - Market Wire

Pluristem Retains KKS as Its CRO for Upcoming Limb Ischemia Clinical Trial

Sun, November 30, 2008

[ Sun, Nov 30th 2008 ] - Market Wire

Regulus Therapeutics, Alnylam Pharmaceuticals, an .. Ever In Vivo Efficacy Data for a microRNA Therap

Fri, November 28, 2008

[ Fri, Nov 28th 2008 ] - Market Wire

SCOR: SCOR establishes reinsurance subsidiary in Moscow

[ Fri, Nov 28th 2008 ] - Market Wire

Schaeffer's Early Edge: eBay, Eli Lilly, and Yahoo!

[ Fri, Nov 28th 2008 ] - Market Wire

MoneyTV; Mutual Merchant Services, Inc.; Imaging3 .. ca, Inc.; OriginOil, Inc.: MoneyTV, Week of 11/28

Thu, November 27, 2008

[ Thu, Nov 27th 2008 ] - Market Wire

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

[ Thu, Nov 27th 2008 ] - Market Wire

FORTIS: Herman Verwilst to Step Down From Fortis Board of Directors

[ Thu, Nov 27th 2008 ] - Market Wire

SORIN GROUP FIRMA ACCORDO DI ACQUISIZIONE DEL BUS .. ELIEVO ENDOSCOPICO DI VASI SANGUIGNI DA DATASCOPE

Wed, November 26, 2008

[ Wed, Nov 26th 2008 ] - Market Wire

Mentor to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Osiris Therapeutics to Present at 20th Annual Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Oculus Innovative Sciences Receives NASDAQ Notification

[ Wed, Nov 26th 2008 ] - Market Wire

Alliance Imaging to Present at the Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Micrus Endovascular to Present at Piper Jaffray 20th Annual Unplugged Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

MedaSorb Technologies Corporation: MedaSorb Techn .. Jones M.D., Elected President of the Renal Physi

[ Wed, Nov 26th 2008 ] - Market Wire

Psychiatric Solutions to Present at the JPMorgan SMid Cap Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Somatic Systems, Inc.: Somatic Systems, Inc. National Television Show Airings Begin

[ Wed, Nov 26th 2008 ] - Market Wire

Mannatech Congratulates Team Mannatech " Athletes on Recent Accomplishments

[ Wed, Nov 26th 2008 ] - Market Wire

Wyeth and Progenics Announce Positive Outcome of .. cutaneous RELISTOR for Opioid-Induced Constipatio

[ Wed, Nov 26th 2008 ] - Market Wire

Tarceva (erlotinib) Endorsed by the U.K. s Nati .. nd Clinical Excellence for Use in Patients with A

Tue, November 25, 2008

[ Tue, Nov 25th 2008 ] - Market Wire

KCI s LifeCell Granted CE Mark for its Strattice Reconstructive Tissue Matrix

[ Tue, Nov 25th 2008 ] - Market Wire

Webcast Alert: Interview with Jay Higham, CEO, IntegraMed America

[ Tue, Nov 25th 2008 ] - Market Wire

HST Global Quarterly Update

[ Tue, Nov 25th 2008 ] - Market Wire

Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market

[ Tue, Nov 25th 2008 ] - Market Wire

Proxy Organizer Responds to Most Recent Improper Actions by Artes Medical

[ Tue, Nov 25th 2008 ] - Market Wire

Health Net Names Chief Medical Officer

[ Tue, Nov 25th 2008 ] - Market Wire

AVANIR to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Abraxis BioScience Announces Agreement to Re-Acqu .. ABRAXANE; Company Highlights Plans to Initiate Ni

[ Tue, Nov 25th 2008 ] - Market Wire

Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Enrollment in Provectus Phase 2 Melanoma Clinical Trial Reaches Halfway Point

[ Tue, Nov 25th 2008 ] - Market Wire

ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Inspire Announces Webcast of Presentation at Piper Jaffray Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Cytori Strengthens European Union Sales, Training and Service Operations

[ Tue, Nov 25th 2008 ] - Market Wire

Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference

Mon, November 24, 2008

[ Mon, Nov 24th 2008 ] - Market Wire

Crucell N.V.: DSM Biologics and Crucell Announce .. PER.C6(R) Licensing Agreement with Gedeon Richter

[ Mon, Nov 24th 2008 ] - Alexa Nuessle

TEEN SUICIDES THIRD LEADING CAUSE OF DEATH Teen Suicide is a Preventable Public Health Problem

[ Mon, Nov 24th 2008 ] - Market Wire

AtriCure to Present at the Piper Jaffray Health Care Conference

[ Mon, Nov 24th 2008 ] - Market Wire

New Noninvasive Prenatal Diagnostic Technology Al .. Diseases Such as Cystic Fibrosis Caused by Single

[ Mon, Nov 24th 2008 ] - Market Wire

Mary Stutts to Join Elan as Senior Vice President and Head of Corporate Relations

[ Mon, Nov 24th 2008 ] - Market Wire

DexCom to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Mon, Nov 24th 2008 ] - Market Wire

Roderick de Greef Named Chairman of Cambridge Heart Board of Directors

[ Mon, Nov 24th 2008 ] - Market Wire

U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma

[ Mon, Nov 24th 2008 ] - Market Wire

Alkermes Corporate Presentation to be Webcast at the NASDAQ Investor Program

[ Mon, Nov 24th 2008 ] - Market Wire

TomoTherapy Names Rafael Vaello Vice President of Global Sales

[ Mon, Nov 24th 2008 ] - Market Wire

Celsion Announces the Appointment of Sean Moran as Chief Financial Officer

[ Mon, Nov 24th 2008 ] - Market Wire

Genzyme Seeks U.S. Approval for Clolar to Treat Adult AML

[ Mon, Nov 24th 2008 ] - Market Wire

OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday,December 4th

[ Mon, Nov 24th 2008 ] - Market Wire

Medtronic Names Francine Kaufman, M.D. to Key Executive Role in Diabetes Business

[ Mon, Nov 24th 2008 ] - Market Wire

LifePoint Hospitals Names Michael S. Coggin Chief Accounting Officer

Thu, November 20, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

Depomed, Inc. Announces Exclusive North American .. Pharmaceuticals, Inc. for DM-1796 (Gabapentin GR

[ Thu, Nov 20th 2008 ] - Market Wire

HealthSpring, Inc. Announces Retirement of Chief Financial Officer, Kevin M. McNamara

[ Thu, Nov 20th 2008 ] - Market Wire

Solvay Pharmaceuticals, Inc. Announces Exclusive .. ent with Depomed, Inc. for Gabapentin GR® for th

[ Thu, Nov 20th 2008 ] - Market Wire

Magellan Health Services to Release 2009 Financial Guidance on December 17, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

Endologix Announces Favorable Powerlink XL Clinical Trial Results

[ Thu, Nov 20th 2008 ] - Market Wire

OSI Pharmaceuticals to Present at the Piper Jaffr .. alth Care Conference on Tuesday, December 2, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio Ships First DPP(R) Tests

[ Thu, Nov 20th 2008 ] - Market Wire

Trinity Biotech: Trinity Biotech Announces Appoin .. ent of Clint Severson as a Non-Executive Director

[ Thu, Nov 20th 2008 ] - Market Wire

Oscient Pharmaceuticals Announces Determination o .. the Consideration Issuable in its Exchange Offer

[ Thu, Nov 20th 2008 ] - Market Wire

OR-Live, Inc.: REMINDER: Prostate Cancer Treatmen .. Using Minimally Invasive Cutting Edge Technology

[ Thu, Nov 20th 2008 ] - Market Wire

Cougar Biotechnology Announces Initiation of Phas .. erone Acetate) in Advanced Breast Cancer Patients

[ Thu, Nov 20th 2008 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. /2Clinical Trial of Elesclomol in Prostate Cancer

[ Thu, Nov 20th 2008 ] - Market Wire

Alnylam Presents Pre-clinical Data from TTR Amyloidosis DevelopmentProgram

[ Thu, Nov 20th 2008 ] - Market Wire

Akorn Enters into a Five Year Contract Manufacturing Agreement toSupply an Ophthalmic Product

Wed, November 19, 2008

[ Wed, Nov 19th 2008 ] - Market Wire

BioTime CEO Dr. Michael West Announces the Launch .. the State of the Stem Cell Industry under the Ob

[ Wed, Nov 19th 2008 ] - Market Wire

Imaging3, Inc.: Imaging3 to Debut 3D Real-Time Im .. and Perspective Interface at the RSNA Trade Show

[ Wed, Nov 19th 2008 ] - Market Wire

Symbollon Pharmaceuticals, Inc.: Symbollon Initiates Sales of IoGen Through Web Site BuyIoGen.com

[ Wed, Nov 19th 2008 ] - Market Wire

CLX Medical, Inc.: CLX Medical, Inc. Updates Status of ThyroTest(R) Close

[ Wed, Nov 19th 2008 ] - Market Wire

El armazÃ³n de colÃ¡geno de ReGen Biologics r .. recomendacionespositivas del panel ortopÃ©dico

[ Wed, Nov 19th 2008 ] - Market Wire

Bond Laboratories Inc. Reports Third Quarter 2008 Results

[ Wed, Nov 19th 2008 ] - Market Wire

Cutera to Present at the Piper Jaffray 20th Annual Health CareConference

[ Wed, Nov 19th 2008 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces the Establishment of Syneron China

[ Wed, Nov 19th 2008 ] - Market Wire

Sanguine Corporation: Sanguine Corporation Announ .. tent to Acquire an MRI Imaging Technology Company

[ Wed, Nov 19th 2008 ] - Market Wire

Inhibiton Therapeutics Announces the Addition of Aaron A. Grunfeld toIts Board of Directors

[ Wed, Nov 19th 2008 ] - Market Wire

Seven Investigator-Initiated Clinical Studies Announced

[ Wed, Nov 19th 2008 ] - Market Wire

LabCorp Launches Tumor MGMT Gene Methylation Testing

[ Wed, Nov 19th 2008 ] - Market Wire

Randomized Phase 2 Study of IMC-A12 for HER2-Expr .. dvancedBreast Cancer Commences Patient Enrollment

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer

Tue, November 18, 2008

[ Tue, Nov 18th 2008 ] - Market Wire

Introgen Announces the Transfer of its Listing of .. Nasdaq Global Market to the Nasdaq Capital Market

[ Tue, Nov 18th 2008 ] - Market Wire

NitroMed and Archemix Announce Merger Agreement

[ Tue, Nov 18th 2008 ] - Market Wire

ReGen Biologics Collagen Scaffold Receives Positive Orthopaedic PanelRecommendations

[ Tue, Nov 18th 2008 ] - Market Wire

Sirona Dental Systems, Inc. Fiscal 2008 Fourth Qu .. l YearEarnings Release Scheduled for December 4th

[ Tue, Nov 18th 2008 ] - Market Wire

Lime Energy Co. Reports Capital Raise and Debt Reduction

[ Tue, Nov 18th 2008 ] - Market Wire

LifeVantage Corporation Announces 1Q FY 2009 Financial and OperatingResults

[ Tue, Nov 18th 2008 ] - Market Wire

FORTIS: Fortis holding statement on Belgian court ruling

[ Tue, Nov 18th 2008 ] - Market Wire

BioSpheres UFE Awareness Campaign Continues with NBC-TV Today ShowAppearance by Beverly Johnson

[ Tue, Nov 18th 2008 ] - Market Wire

FDA Extends METOZOLV"¢ ODT Review Date

[ Tue, Nov 18th 2008 ] - Market Wire

Salix Announces Issuance of U.S. Patent for Rifaximin

[ Tue, Nov 18th 2008 ] - Market Wire

Immunosyn Corporation Files 10-Q

[ Tue, Nov 18th 2008 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. e Piper Jaffray 20th Annual Healthcare Conference

[ Tue, Nov 18th 2008 ] - Market Wire

StemCells, Inc. Closes $20 Million Equity Financing

[ Tue, Nov 18th 2008 ] - Market Wire

Metcare of Florida Scores High Marks in DSS Research Survey on PatientSatisfaction

Mon, November 17, 2008

[ Mon, Nov 17th 2008 ] - Market Wire

Acusphere, Inc. Announces Resignation of Howard Bernstein

[ Mon, Nov 17th 2008 ] - Market Wire

Resumen: Gilead Sciences anuncia notificaciÃ³n de presentaciÃ³n ANDA para Truvada

[ Mon, Nov 17th 2008 ] - Market Wire

Webcast Alert: Lpath Third Quarter Business Review Teleconference

[ Mon, Nov 17th 2008 ] - Market Wire

Vicor Technologies, Inc.: Vicor Technologies Issu .. scusses Milestones, Progress Towards Commercializ

[ Mon, Nov 17th 2008 ] - Market Wire

Somatic Systems, Inc.: Somatic Systems, Inc. Comp .. t Round of Financials for Audits for OTCBB Uplist

[ Mon, Nov 17th 2008 ] - Market Wire

Altus Pharmaceuticals Reaffirms Plan to Submit New Drug Applicationfor Trizytek Approval

[ Mon, Nov 17th 2008 ] - Market Wire

OraSure Technologies to Participate at the Lazard Capital Markets5th Annual Healthcare Conference

[ Mon, Nov 17th 2008 ] - Market Wire

Targeted Genetics: Targeted Genetics' Board of Di .. G. Susan Robinson, President and CEO, as Director

[ Mon, Nov 17th 2008 ] - Market Wire

RegeneRxs Experimental Drug Promotes Healing in Patients WithNon-Healing Corneal Ulcers

[ Mon, Nov 17th 2008 ] - Market Wire

Juanell Hefner Named President of MHN

[ Mon, Nov 17th 2008 ] - Market Wire

Patients Experienced Nearly a 70% Reduction in Pa .. When Using MPMMedical's Regenecare Wound Care Gel

[ Mon, Nov 17th 2008 ] - Market Wire

St. Jude Medical Announces Japanese Approval and Launch of VictoryFamily of Pacemakers

[ Mon, Nov 17th 2008 ] - Market Wire

ZYTO Corp Announces Profitable Q3 08

[ Mon, Nov 17th 2008 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Reaches .. Protocol Assessment for Phase 3 Thymalfasin Tria

ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference

_{//health-fitness.news-articles.net/content/2008/ .. r-jaffray-20th-annual-healthcare-conference.html}
^{Published in Health and Fitness on Tuesday, November 25th 2008 at 6:05 GMT by Market Wire}

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Piper Jaffray 20th Annual Healthcare Conference being held at The Palace Hotel in New York, New York. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of the Company and its progress in key programs on Tuesday, December 2, 2008 at 1:00 p.m. (ET).

The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at [ http://www.ariad.com/investor ]. A replay will be available on the ARIAD website approximately twenty-four hours after the presentation and will be archived for two weeks.

About ARIAD

ARIAD is engaged in the discovery and development of breakthrough medicines to treat cancer by regulating cell signaling with small molecules. ARIAD is developing a comprehensive approach to patients with cancer that addresses the greatest medical need - aggressive and advanced-stage cancers for which current treatments are inadequate. ARIAD has a global partnership with Merck & Co., Inc. to develop and commercialize deforolimus, ARIAD's lead cancer product candidate, which is in Phase 3 clinical development. ARIAD's second oncology product candidate, oral AP24534, is a novel multi-targeted kinase inhibitor in Phase 1 clinical development in hematological cancers. ARIAD has an exclusive license to pioneering technology and patents related to certain NF-κB treatment methods, and the discovery and development of drugs to regulate NF-κB cell-signaling activity, which may be useful in treating certain diseases. Additional information about ARIAD can be found on the web at http://www.ariad.com.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Mon, Nov 24th 2008 ] - Market Wire

U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma

[ Mon, Nov 24th 2008 ] - Market Wire

OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday,December 4th

[ Thu, Nov 20th 2008 ] - Market Wire

Depomed, Inc. Announces Exclusive North American .. Pharmaceuticals, Inc. for DM-1796 (Gabapentin GR

[ Thu, Nov 20th 2008 ] - Market Wire

OSI Pharmaceuticals to Present at the Piper Jaffr .. alth Care Conference on Tuesday, December 2, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

Cougar Biotechnology Announces Initiation of Phas .. erone Acetate) in Advanced Breast Cancer Patients

[ Thu, Nov 20th 2008 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. /2Clinical Trial of Elesclomol in Prostate Cancer

[ Thu, Nov 20th 2008 ] - Market Wire

Alnylam Presents Pre-clinical Data from TTR Amyloidosis DevelopmentProgram

[ Wed, Nov 19th 2008 ] - Market Wire

Randomized Phase 2 Study of IMC-A12 for HER2-Expr .. dvancedBreast Cancer Commences Patient Enrollment

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer

[ Tue, Nov 18th 2008 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. e Piper Jaffray 20th Annual Healthcare Conference

[ Mon, Nov 17th 2008 ] - Market Wire

RegeneRxs Experimental Drug Promotes Healing in Patients WithNon-Healing Corneal Ulcers

[ Mon, Nov 17th 2008 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Reaches .. Protocol Assessment for Phase 3 Thymalfasin Tria